Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
not much of a market reaction yet. waiting details
Bear raid
Looking forward to next earnings report. Hopefully beat revenues and further guidance. Snda info
rox another "Frost play" have a small position
http://ih.advfn.com/p.php?pid=nmona&article=73510504
pdufa 8-29-17
Idra missed adding today. Moving up a.h after baker bro added
scroll to vaccine multi tasker. Heard this on my way home from work
http://newyork.cbslocal.com/audio/health-and-well-being/
Psdv. May take a starter Monday for a long ten play
Canceling a meeting sometimes is good if fda does not need or want recommendations. This was delayed at first because so much data for fda to review for pdufa .worry is thwy found something that needs to be addressed before thwy can give briefing doc to committee
Risk vs reward seems to favor holding through data. Lots of room to run
Getting close to re-loading area
Alim hoping to get some shares if it drops dOwn near offering price (1.40). Agree this is a good long.
Vcel starter position. 2.30 this will be a runner heading into pdufa.
ontxw expiration 5 years after issuance
http://files.shareholder.com/downloads/AMDA-1XRSSC/0x0xS1047469-16-14224/1130598/filing.pdf
Onconova Therapeutics, Inc.
We are distributing to holders of our common stock and to holders of certain of our outstanding warrants who are entitled to participate in this offering, at no charge, non-transferabl
subscription rights to purchase units. Each unit, which we refer to as a Unit, consists of one share of common stock and 0.75 of a tradable warrant representing the right to purchase one share of
common stock, which we refer to as the Warrants. We refer to the offering that is the subject of this prospectus as the Rights Offering.
In the Rights Offering, you will receive 1.5 subscription rights for each share of common stock or each share of common stock underlying our participating warrants owned at 5:00 PM Eastern
Time, on July 7, 2016, the record date of the Rights Offering, or the Record Date. The common stock and the Warrants comprising the Units will separate upon the effectiveness of the exercise of the
rights and will be issued as separate securities, and the Units will not trade as a separate security. The subscription rights will not be tradable.
Each subscription right will entitle you to purchase one Unit, which we refer to as the Basic Subscription Right, at a subscription price per Unit of $4.90, which we refer to as the Subscription
Price. The Warrants entitle the holder to purchase one share of common stock at an exercise price of $5.88 per share, 120% of the per Unit price, from the date of issuance through its expiration five
years after the date of issuance. If you exercise your Basic Subscription Rights in full, and other shareholders or participating warrant holders do not, you will be entitled to an over-subscription
privilege to purchase a portion of the unsubscribed Units at the Subscription Price, subject to proration, which we refer to as the Over-Subscription Privilege. Each subscription right consists of a
Basic Subscription Right and an Over-Subscription Privilege, which we refer to as the Subscription Right
Think it hits 5.50 will be interesting
Maybe restricted because a Martin S like person is going to buy up the float lol. I wish lol.
Data early 2016. Looking for january bump here from 2.44
Catalysts in January plus end of tax loss selling. Looking for 20 percent next few weeks from 1.42
Starter 2.20 agree that substantial news will make this fly with the float so small
Trevena (TRVN) PT Raised to $20 at Wedbush
September 1, 2015 6:44 AM EDT Send to a Friend
Wedbush analyst Heather Behanna reiterated an Outperform rating and boosted her price target on Trevena (NASDAQ: TRVN) to $20.00
http://www.streetinsider.com/Analyst+Comments/Trevena+%28TRVN%29+PT+Raised+to+%2420+at+Wedbush/10857070.html?si_client=st
short interest http://www.nasdaq.com/symbol/trvn/short-interest
Going to pick some up today... Trim off some of my other stocks with low institutional ownership
Hrtx. Nda resubmission soon. Got in low 7's and exited just below 8 trying to swing...this should move by end of year. Exited way to early looking to get back in
Wlt tempted to take a position with tight stop. May not be a bad idea to leave some profits in for long term?
Thinking ofvgrabbing a position here. Too much potential here and 30 mill in coffers
Bought back in today. Easy quick 10%
Psdv hoping to get a bounce leading up to conference call tomorrow
Psdv. Monday should be interesting
Psdv Think that having two companies invilved may have caused delay in announcement today? Nerve racking though
There are two companies involved so delayed today may have been because of issuing PR together
trading action different. Than last years pdufa ti say least
Psdv think approval coming
http://www.biotech-now.org/wp-content/uploads/2012/03/trytry-again.jpg
Psdv has catalysts that will bring pps back up if they get a crl. Holding thru pdufa. I do not think there will be a crl.
http://www.biotech-now.org/wp-content/uploads/2012/03/trytry-again.jpg
disregard was wrong board
Not sure on open interest 5 strikes. Hoping next week is run up week
Bought at 4.64 again should go up after OPEX
nice to see some movement today. Think the post market study requirements on nktr and opex had impact on price this week.
hopefully we will see some covering today. Had an order fill at 4.86 yesterday for 750 shares. With opex do not expect to see 6 for a week or so.
Have full position now and could not add more on Friday. I think early approval is a possibility and others may share this opinion. Friday was last dip.
Jmo